Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease

Thorax

Volumn 60, Issue 10, 2005, Pages 834-841

  Koechlin, C ^a   Maltais, F ^b   Saey, D ^b   Michaud, A ^b   LeBlanc, P ^b   Hayot, M ^a   Prefaut C ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOFUSCIN; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HUMAN; HYPOXEMIA; LIPID PEROXIDATION; MALE; MUSCLE BIOPSY; MUSCLE EXERCISE; MYOSITIS; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; QUADRICEPS FEMORIS MUSCLE; VASTUS LATERALIS MUSCLE;

AGED; ANOXEMIA; ANTHROPOMETRY; BIOLOGICAL MARKERS; BIOPSY; CHRONIC DISEASE; EXERCISE; FORCED EXPIRATORY VOLUME; HUMANS; MUSCLE, SKELETAL; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY;

EID: 26844550676     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.037531     Document Type: Article

References (50)

1. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996;51:348-50.
2. Langen RO, Korn SH, Wouters EFM. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 2003;35:226-35.
3. Couillard A, Maltais F, Saey D, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1664-9.
4. Reid MB. Nitric oxide, reactive oxygen species, and skeletal muscle contraction. Med Sci Sports Exerc 2001;33:371-6.
5. American Thoracic Society and European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:S1-40.
6. Koechlin C, Couillard A, Simar D, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2004;169:1022-7.
7. Raguso CA, Guinot SL, Janssens JP, et al. Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude. Curr Opin Clin Nutr Metab Care 2004;7:411-7.
8. Hoppeler H, Vogt M, Weibel ER, et al. Response of skeletal muscle mitochondria to hypoxia. Exp Physiol 2003;88:1, 109-19.
9. Chandel NS, Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol 2000;88:1880-9.
10. Simon-Schnass IM. Risk of oxidative stress at high altitude and possible benefit of antioxidant supplementation. In: Sen CK, Packer L, Hanninen, eds. Handbook of oxidants and antioxidants in exercise. Amsterdam: Elsevier, 2000:555-77.
11. Bailey DM, Davies B, Young IS. Intermittent hypoxic training: implications for lipid peroxidation induced By acute normoxic exercise in active men. Clin Sci (Lond) 2001;101:465-75.
12. Martinelli M, Winterhalder R, Cerretelli P, et al. Muscle lipofuscin content and satellite cell volume is increased after high altitude exposure in humans. Experientia 1990;46:672-6.
13. Lundby C, Pilegaard H, van Hall G, et al. Oxidative DNA damage and repair in skeletal muscle of humans exposed to high-altitude hypoxia. Toxicology 2003;192:229-36.
14. Serres I, Gautier V, Varray A, et al. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998;113:900-5.
15. Reid MB, Li YP. Cytokines and oxidative signalling in skeletal muscle. Acta Physiol Scand 2001;171:225-32.
16. Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 1994;54:1425-30.
17. Matsui H, Ihara Y, Fujio Y, et al. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc Res 1999;42:104-12.
18. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-90.
19. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1179-84.
20. Andersen P, Adams RP, Sjogaard G, et al. Dynamic knee extension as model for study of isolated exercising muscle in humans. J Appl Physiol 1985;59:1647-53.
21. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003;22:1-2.
22. Mellemgaard K. The alveolar arterial oxygen difference: its size and components in normal man. Acta Physiol Scand 1966;67:10-20.
23. Knudson RJ, Slatin RC, Lebowitz MD, et al. The maximal expiratory flow-volume curve: normal standards, variability and effects of age. Am Rev Respir Dis 1976;113:587-600.
24. Marquis K, Debigaré R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-13.
25. Bergström J. Electrolytes in man: determination by neutron activation analysis on needle biopsy specimens: a study on normal subjects, kidney patients and patients with chronic diarrhoea. Scand J Clin Lab Invest 1962;14:1-10.
26. Whittom F, Jobin J, Simard MA, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998;30:1467-74.
27. Mabuchi K, Sréter FA. Actomyosin ATPase: quantitative measurement of activity in cryostat sections. Muscle Nerve 1980;3:227-32.
28. Allaire J, Maltais F, LeBlanc P, et al. Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Muscle Nerve 2002;25:383-9.
29. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
30. Nakamura W, Hosoda S, Hayashi K. Purification and properties of rat liver glutathione peroxidase. Biochim Biophys Acta 1974;358:251-61.
31. Sun M, Zigman S. An improved spectrophotometric assay for superoxide dismutase cased on epinephrine autoxiaation. Anal Biochem 1978;90:81-9.
32. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986;1:307-10.
33. Noguera A, battle S, Miralles C, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001;56:432-7.
34. Oudijk EJD, Lammers JWJ, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J 2003;22:S5-13.
35. Rahman I, MacNee W. Role of transcription factors in inflammatory lung disease. Thorax 1998;53:601-12.
36. Agusti A, Morla M, Sauleda J, et al. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 2004;59:483-7.
37. McCord JM, Roy RS, Schaffer SW. Free radicals and myocardial ischemia. The role of xanthine oxidase. Adv Myocardiol 1985;5:183-9.
38. Heunks L, Vina J, Cees L, et al. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999;277:R1697-700.
39. Terasawa K, Fujiwara T, Sakai A, et al. Comparison of muscle force, muscle endurance, and electromyogram activity during an expedition at high altitude. Int J Biometeorol 1996;39:111-5.
40. Esposito F, Orizio C, Parrinello G, et al. Chronic hypobaric hypoxia does not affect electro-mechanical muscle activities during sustained maximal isometric contractions. Eur J Appl Physiol 2003;90:337-43.
41. Fulco CS, Cymerman A, Muza SR, et al. Adductor pollicis muscle fatigue during acute and chronic altitude exposure and return to sea level. J Appl Physiol 1994;77:179-83.
42. Zattara-Hartmann MC, Badier M, Guillot C, et al. Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing. Muscle Nerve 1995;18:495-502.
43. Sohal RS, Brunk UT. Lipofuscin as an indicator of oxidative stress and aging. Adv Exp Med Biol 1989;266:17-29.
44. Haliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr 1993;57:715-24.
45. Levine RL, Williams JA, Stadtman ER, et al. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346-57.
46. Liu J, Yeo HC, Overvik-Douki E, et al. Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. J Appl Physiol 2000;89:21-8.
47. Alessio HM, Goldfarb AH. Lipid peroxidation and scavenger enzymes during exercise: adaptive response to training. J Appl Physiol 1988;64:1333-6.
48. Moller P, Loft S, Lundby C, et al. Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans. FASEB J 2001;15:1181-6.
49. Frankiewicz-Jozko A, Faff J, Sieradzan-Gabelska B. Changes in concentrations of tissue free radical marker and serum creatine kinase during the post-exercise period in rats. Eur J Appl Physiol 1996;74:470-4.
50. Cannon. G, St Pierre. B. Cytokines in exertion-induced skeletal muscle injury. Mol Cell Biochem 1998;179:159-67.